Cita APA

Weinrauch, L. A., D’Elia, J. A., Weir, M. R., Bunnapradist, S., Finn, P., Liu, J., . . . Monaco, A. P. (2017). Does diabetes impact therapeutic immunomodulation therapy decisions for kidney transplant recipients? Data from the Folic Acid for Vascular Outcome Reduction in Transplant (FAVORIT) trial. Int J Nephrol Renovasc Dis.

Chicago Style Citation

Weinrauch, Larry A., John A. D’Elia, Matthew R. Weir, Suphamai Bunnapradist, Peter Finn, Jiankang Liu, Brian Claggett, i Anthony P. Monaco. "Does Diabetes Impact Therapeutic Immunomodulation Therapy Decisions for Kidney Transplant Recipients? Data From the Folic Acid for Vascular Outcome Reduction in Transplant (FAVORIT) Trial." Int J Nephrol Renovasc Dis 2017.

Cita MLA

Weinrauch, Larry A., et al. "Does Diabetes Impact Therapeutic Immunomodulation Therapy Decisions for Kidney Transplant Recipients? Data From the Folic Acid for Vascular Outcome Reduction in Transplant (FAVORIT) Trial." Int J Nephrol Renovasc Dis 2017.